Fms-like tyrosine kinase-3 ligand alters antigen-specific responses to infections after severe burn injury.
Fms-like tyrosine kinase-3 ligand alters antigen-specific responses to infections after severe burn injury.
复制标题
DOI:
10.1097/shk.0b013e31819e2937
复制
发表时间:
2009-10
期刊:
影响因子:
--
通讯作者:
Toliver-Kinsky T
中科院分区:
文献类型:
--
作者:
Bohannon J;Fang G;Cui W;Sherwood E;Toliver-Kinsky T
Burn patients are susceptible to opportunistic infections due partly to decreased immune functions, especially Th1-driven antigen-specific responses, which are regulated by dendritic cells. The dendritic cell growth factor, fms-like tyrosine kinase-3 ligand (FL), has been shown to increase resistance to P. aeruginosa, in a dendritic cell-dependent manner, in a mouse model of burn wound infection. The specific mechanisms of protection are not known. This study tested the hypothesis that FL can enhance production of P. aeruginosa-specific antibodies following burn wound infection. Mice that had been previously exposed to P. aeruginosa were infected after burn injury by wound inoculation, or challenged by intraperitoneal injection of heat-killed P. aeruginosa. In response to wound infection, FL treatments enhanced bacterial clearance and induced a shift from IgM towards IgG and IgA. However, serum levels of neither P. aeruginosa-specific antibodies nor IFN-γ were significantly increased by FL, possibly due to decreased systemic exposure to bacteria. Following challenge with heat-killed bacteria, which ensured equal exposures, FL-treated mice produced significantly greater levels of P. aeruginosa-specific IgG2a, which correlated with an increase in serum levels of IFN-γ and enhanced opsonization capacity. IL-12, IL-10, and TGF-β were significantly increased in FL-treated mice, regardless of the type of challenge. These findings indicate that FL treatments after burn injury enhance cytokine responses to recall antigens and increase bacterial clearance. Additionally, through its ability to promote Th1-associated antigen-specific responses, FL may have potential as an immunotherapy to enhance adaptive immunity following severe burn injury.